Drug Database
Back to search

Switzerland· 66338003

Parsabiv 10.0 mg, Injektionslösung

A etelcalcetide product containing etelcalcetidum, registered in Switzerland by Amgen Switzerland AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC H05BX04

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedParsabiv 10.0 mg, InjektionslösungATCH05BX04REGISTER NO.66338003PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about etelcalcetidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Etelcalcetide is registered in 14 of 19 countries.

Countries holding a registration under ATC H05BX04 (etelcalcetide), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 10 of them publish a price we can compare per daily dose
Search etelcalcetide products by name

Etelcalcetide · ATC H05BX04

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
etelcalcetidum
Manufacturer
Amgen Switzerland AG
Country
Switzerland (CH)
ATC code
H05BX04
ATC class
Etelcalcetide
Defined daily dose
2.1 mg, P
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680663380034
    6 Durchstf 2 ml
    CHF 322.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

20 interactions on record for etelcalcetide.

Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check etelcalcetide against other medicinesHow interaction checks work

Etelcalcetide · interactions on record

20 records

  • 19 severe
  • 1 moderate

Most severe, free to view

  • FurosemideC03CA01severe
  • BumetanideC03CA02severe
  • TorasemideC03CA04severe
  • Etacrynic acidC03CC01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Etelcalcetide in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etelcalcetide products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Parsabiv
  • Norway · Parsabiv

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9a90b34c-6938-43be-b7a2-d61bec72937f
GET /v1/drugs/9a90b34c-6938-43be-b7a2-d61bec72937f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "etelcalcetidum 10 mg",
  "valid_from": "2018-04-01",
  "limitations": "[{\"description\":\"Zur Behandlung von sekundärem Hyperparathyreoidismus bei hämodialysepflichtigen Patienten mit Parathormon-Ausgangswerten von über 300 pg/ml. Die Verschreibung muss durch einen Facharzt FMH für Nephrologie erfolgen.<br>\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2018-04-01\"}]",
  "galenic_form": "Inj Lös 10 mg/2ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2018-04-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about etelcalcetide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console